Conversation with The Cancer LetterFree Patricia Goldsmith: This is the “Moonstab,” or, maybe, the “Moonshaft” March 17, 2017Vol.43 No.11By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Blase Polite: This was put together by folks who have no sense of how research is done March 17, 2017Vol.43 No.11By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Ellen Sigal: This is not a grasstops issue anymore, this is really grassroots March 17, 2017Vol.43 No.11By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Nancy Davidson: This is the time for investment, not for retreat March 17, 2017Vol.43 No.11By Paul Goldberg
Conversation with The Cancer LetterFree John Porter: If you want to make America great, you don’t take America’s worldwide scientific lead and cut it March 17, 2017Vol.43 No.11By Paul Goldberg
Conversation with The Cancer LetterFree Steve Hahn and his plan for rescuing MD Anderson March 03, 2017Vol.43 No.09By Paul Goldberg
Conversation with The Cancer LetterFree Marcia Crosse: This “failure of the adverse event reporting system” should serve as a “wake up call” February 24, 2017Vol.43 No.08By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Giusti: The $40 million multiple myeloma dataset will help predict risk and clinical response February 10, 2017Vol.43 No.06By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Simon: The moonshot will continue, but the electronic health record industry must step up January 13, 2017Vol.43 No.02By Matthew Bin Han Ong
Conversation with The Cancer LetterFree FDA: For Hospitals that Significantly Violated Federal Adverse Event Reporting Requirement, No Additional Action Necessary December 16, 2016Vol.42 No.46By Matthew Bin Han Ong
